Vasanthakumar, Aparna <br/><br/>
Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.  [electronic resource] 

 -  PloS one  2018 
 - e0198296 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0198296  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia, Hemolytic--chemically induced<br/>Antiviral Agents--adverse effects<br/>Female<br/>Humans<br/>Interferons<br/>Interleukins--genetics<br/>Male<br/>Polymorphism, Genetic<br/>Pyrophosphatases--metabolism<br/>Ribavirin--adverse effects<br/>Inosine Triphosphatase